Prevalence and clinical significance of left atrial remodeling in competitive athletes

OBJECTIVES In the present study we assessed the distribution and clinical significance of left atrial (LA) size in the context of athlete's heart and the differential diagnosis from structural heart disease, as well as the proclivity to supraventricular arrhythmias. BACKGROUND The prevalence, clinical significance, and long-term arrhythmic consequences of LA enlargement in competitive athletes are unresolved. METHODS We assessed LA dimension and the prevalence of supraventricular tachyarrhythmias in 1,777 competitive athletes (71 % of whom were males), free of structural cardiovascular disease, that were participating in 38 different sports. RESULTS The LA dimension was 23 to 50 mm (mean, 37 +/- 4 mm) in men and 20 to 46 mm (mean, 32 4 mm) in women and was enlarged (i.e., transverse dimension >= 40 nun) in 347 athletes (20 %), including 38 (2 %) with marked dilation (>= 45 mm). Of the 1,777 athletes, only 14 (0.8 %) had documented, symptomatic episodes of either paroxysmal atrial fibrillation (n = 5; 0.3 %) or supraventricular tachycardia (n = 9; 0.5 %), which together occurred in a similar proportion in athletes with (0.9 %) or without (0.8 % p = NS) LA enlargement. Multivariate regression analysis showed LA enlargement in athletes was largely explained by left ventricular cavity enlargement (R-2 = 0.53) and participation in dynamic sports (such as cycling, rowing/canoeing) but minim-ally by body size. CONCLUSIONS In a large population of highly, trained athletes, enlarged LA dimension 40 mm was relatively common (20 %), with the upper limits of 45 mm in women and 50 mm in men distinguishing physiologic cardiac remodeling (athlete's heart) from pathologic cardiac conditions. Atrial fibrillation and other supraventricular tachyarrhythillias proved to be uncommon (prevalence < 1 %) and similar to that in the general Population, despite the frequency of LA enlargement. Left atrial remodeling in competitive athletes may be regarded as a physiologic adaptation to exercise conditioning, largely without adverse clinical consequences. (c) 2005 by the American College of Cardiology Foundation.